Cost-Effectiveness of Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement

Journal of the American College of Cardiology

Volumn 67, Issue 1, 2016, Pages 29-38

  Reynolds, Matthew R ^a,b   Lei, Yang ^c,d   Wang, Kaijun ^c   Chinnakondepalli, Khaja ^c   Vilain, Katherine A ^c   Magnuson, Elizabeth A ^c,e   Galper, Benjamin Z ^f   Meduri, Christopher U ^g   Arnold, Suzanne V ^c,e   Baron, Suzanne J ^c,e   Reardon, Michael J ^h   Adams, David H ⁱ   Popma, Jeffrey J ^j   Cohen, David J ^c,e  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c Mid America Heart Institute   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g PIEDMONT HEART INSTITUTE   (United States)

^h HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

more..

Author keywords

cost benefit analysis; heart valve prosthesis; Key Words aortic stenosis; quality adjusted life years; transcatheter valve therapy

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; CARDIOVASCULAR MORTALITY; COMORBIDITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART VALVE BIOPROSTHESIS; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; LENGTH OF STAY; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CENTER; REVIEW; SELF EXPANDING STENT; SURGICAL AORTA VALVE REPLACEMENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; VASCULAR ACCESS; VERY ELDERLY; AORTIC VALVE STENOSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DEVICES; ECONOMICS; HEART VALVE PROSTHESIS; HOSPITAL COST; PROSTHESIS DESIGN; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; COST-BENEFIT ANALYSIS; FEMALE; HEART VALVE PROSTHESIS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; PROSTHESIS DESIGN; QUALITY-ADJUSTED LIFE YEARS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84952923438     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.046     Document Type: Article

References (23)

1. M.B. Leon, C.R. Smith, M. Mack, et al. for the PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
2. J.J. Popma, D.H. Adams, M.J. Reardon, et al. for the CoreValve United States Clinical Investigators Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery J Am Coll Cardiol 63 2014 1972 1981
3. C.R. Smith, M.B. Leon, M.J. Mack, et al. for the PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
4. D.H. Adams, J.J. Popma, M.J. Reardon, et al. for the U.S. CoreValve Clinical Investigators Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
5. M.R. Reynolds, E.A. Magnuson, K. Wang, et al. for the PARTNER Investigators Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B) Circulation 125 2012 1102 1109
6. R.L. Osnabrugge, A.P. Kappetein, M.R. Reynolds, and D.J. Cohen Cost-effectiveness of transcatheter valvular interventions: economic challenges EuroIntervention 9 Suppl 2013 S48 S54
7. M.R. Reynolds, E.A. Magnuson, Y. Lei, et al. for the PARTNER Investigators Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A) J Am Coll Cardiol 60 2012 2683 2692
8. M. Neyt, H. Van Brabandt, S. Devriese, and S. Van De Sande A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population BMJ Open 2 2012 pii:e001032
9. M.J. Reardon, D.H. Adams, N.S. Kleiman, and et al. 2-Year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement J Am Coll Cardiol 66 2015 113 121
10. S.M. O'Brien, D.M. Shahian, G. Filardo, et al. for the Society of Thoracic Surgeons Quality Measurement Task Force The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery Ann Thorac Surg 88 Suppl 1 2009 S23 S42
11. M.C. Weinstein, J.E. Siegel, M.R. Gold, M.S. Kamlet, and L.B. Russell Recommendations of the Panel on Cost-effectiveness in Health and Medicine JAMA 276 1996 1253 1258
12. D.J. Cohen, H.M. Krumholz, C.A. Sukin, et al. for the Stent Restenosis Study Investigators In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty: results from a randomized clinical trial Circulation 92 1995 2480 2487
13. Centers for Medicare and Medicaid Services. 100% MedPAR Inpatient Hospital National Data for Fiscal Year 2011: Short Stay Inpatient by DRG. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareFeeforSvcPartsAB/Downloads/DRG11.pdf. Accessed October 28, 2015.
14. M.W. Smith, P.G. Barnett, C.S. Phibbs, and T.H. Wagner Microcost Methods for Determining VA Healthcare Costs 2010 Health Economics Resource Center (HERC) Menlo Park, CA Available at: http://www.herc.research.va.gov/files/BOOK-458.pdf Accessed November 3, 2015
15. E. Arias United States Life Tables, 2009. National Vital Statistics Reports. Vol. 62, no. 7 2014 National Center for Health Statistics Hyattsville, MD
16. J.W. Shaw, J.A. Johnson, and S.J. Coons US valuation of the EQ-5D health states: development and testing of the D1 valuation model Med Care 43 2005 203 220
17. S.V. Arnold, M.R. Reynolds, K. Wang, et al. for the CoreValve U.S. Pivotal Trial Investigators Health status after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis at increased surgical risk: results from the CoreValve US Pivotal Trial J Am Coll Cardiol Intv 8 2015 1207 1217
18. J.L. Anderson, P.A. Heidenreich, P.G. Barnett, and et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 2304 2322
19. M. Williams, S.K. Kodali, R.T. Hahn, and et al. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve) J Am Coll Cardiol 63 2014 1522 1528
20. P.J. Neumann, J.T. Cohen, and M.C. Weinstein Updating cost-effectiveness-the curious resilience of the $50,000-per-QALY threshold N Engl J Med 371 2014 796 797
21. S.V. Arnold, Y. Lei, M.R. Reynolds, et al. for the PARTNER Investigators Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial Circ Cardiovasc Interv 7 2014 829 836
22. V. Babaliaros, C. Devireddy, S. Lerakis, and et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis J Am Coll Cardiol Intv 7 2014 898 904
23. R. Marcantuono, J. Gutsche, M. Burke-Julien, and et al. Rationale, development, implementation, and initial results of a fast track protocol for transfemoral transcatheter aortic valve replacement (TAVR) Catheter Cardiovasc Interv 85 2015 648 654